J. Kama

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.

A. Young, S. Augood, E. Stern, 2005, Human molecular genetics.

Decreased Lin7b Expression in Layer 5 Pyramidal Neurons May Contribute to Impaired Corticostriatal Connectivity in Huntington Disease

C. Weiller, A. Young, K. Lindenberg, 2010, Journal of neuropathology and experimental neurology.

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease

M. DiFiglia, S. Hersch, D. Hoyer, 2010, Molecular Neurodegeneration.

Cysteine Oxidation within N-terminal Mutant Huntingtin Promotes Oligomerization and Delays Clearance of Soluble Protein*

S. Hersch, A. Bush, R. Cherny, 2011, The Journal of Biological Chemistry.

Mechanisms of Copper Ion Mediated Huntington's Disease Progression

S. Hersch, A. Bush, R. Cherny, 2007, PloS one.